Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sight Sciences (SGHT) Research & Development (2020 - 2026)

Sight Sciences has reported Research & Development over the past 6 years, most recently at $2.4 million for Q4 2025.

  • For Q4 2025, Research & Development fell 43.23% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $14.6 million, down 18.81%, while the annual FY2025 figure was $14.6 million, 18.81% down from the prior year.
  • Research & Development for Q4 2025 was $2.4 million at Sight Sciences, down from $3.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $6.1 million in Q3 2022 and troughed at $2.4 million in Q4 2025.
  • A 5-year average of $4.4 million and a median of $4.4 million in 2021 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: surged 145.74% in 2021 and later crashed 43.23% in 2025.
  • Year by year, Research & Development stood at $4.4 million in 2021, then increased by 19.78% to $5.2 million in 2022, then tumbled by 34.51% to $3.4 million in 2023, then increased by 25.27% to $4.3 million in 2024, then crashed by 43.23% to $2.4 million in 2025.
  • Business Quant data shows Research & Development for SGHT at $2.4 million in Q4 2025, $3.4 million in Q3 2025, and $4.4 million in Q2 2025.